Pricing Log in Create free account

Charles River Laboratories International, Inc. (CRL) vs Labcorp Holdings Inc. (LH)

Charles River Laboratories International, Inc. and Labcorp Holdings Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $29.5B against $14.9B — 2.0× the size. Labcorp Holdings Inc. trades at the lower P/E: 29.5× against 300×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.02% against −1.16%. Labcorp Holdings Inc. has the higher net margin (6.88% vs 1.01%) and the higher return on invested capital (6.76% vs 1.81%). Across the 22 metrics below, Labcorp Holdings Inc. leads on 17 and Charles River Laboratories International, Inc. on 5.

Valuation

Metric CRL LH Diagnostics & Research median
P/E 300.09 29.53 34.52
P/S 3.77 2.01 4.24
P/B 4.64 3.32 3.42
Price to free cash flow 37.56 25.40 33.51
EV/EBITDA 31.20 15.61 23.44
EV/Sales 4.34 2.36 5.18
Earnings yield 0.33% 3.39% (1.50%)
Free cash flow yield 2.66% 3.94% 0.00%

Profitability

Metric CRL LH Diagnostics & Research median
Gross margin 33.33% 28.96% 48.32%
Operating margin 4.00% 10.29% (5.68%)
Net margin 1.01% 6.88% (4.10%)
Free cash flow margin 10.05% 8.87% 0.00%
Return on equity 1.21% 11.45% 0.00%
Return on assets 0.54% 5.40% (6.05%)
Return on invested capital 1.81% 6.76% 0.00%

Growth

Metric CRL LH Diagnostics & Research median
Revenue growth (TTM) (1.16%) 6.02% 8.99%
EPS growth (last fiscal year) (1,555.00%) 18.33% 20.36%
Revenue growth, 5-year CAGR 6.55% (0.04%) 7.30%
Net income growth, 5-year CAGR 0.00% (10.85%) 0.00%

Health

Metric CRL LH Diagnostics & Research median
Debt to equity 0.76 0.60 0.01
Current ratio 1.41 1.41 2.27
Net debt to EBITDA 3.24 2.23 0.68

Dividend

Metric CRL LH Diagnostics & Research median
Dividend yield — 0.79% 0.67%
Payout ratio — 0.24 0.20

Size

Metric CRL LH Diagnostics & Research median
Market cap 14.94b 29.50b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack